Merck
CN
HomeServicesProduct ServicesSingle-Use and Filter Validation ServicesExtractables and Leachables

Extractables and Leachables

BioReliance® extractables and leachables testing services

Understanding the potential of leachables to affect patient safety is a critical step in the validation strategy of any biopharmaceutical manufacturer. Our Extractables & Leachables (E&L) services will consider a risk-based approach to determine if patient safety is adversely affected by plastic materials coming into contact with the final drug product during your process, while assessing potential toxicity to patients. 

In accordance with regulatory expectations, our E&L team will conduct a thorough interpretation of the extractables datasets while evaluating the criticality of your process train and single-use system. We can determine:

  • Single-use components to be evaluated
  • Choice of analytical method
  • Model solvent(s)
  • Relevant worst-case conditions

Seamless and robust E&L assessment

To demonstrate that filtration devices and single-use systems materials utilized in your manufacturing will not adversely affect a drug product’s safety for patients, we assist you in conducting a risk assessment and recommend a step-by-step validation strategy.

An Easier Way to Achieve a Seamless and Robust E&L Assessment

Collect

Extractables Dossiers
Why?
Compile standard extractables data for contact material present in the process, including BioPhorum protocol and USP <665> approaches

EMPROVE® PROGRAM

What?
Extractables Dossiers:
  • Enabling initial qualifi cation
  • Ensuring product functionality
  • Assuring material safety
Where?
Operational Excellence Dossiers

    Interpret

    Extractables Data
    Why?
    Identify process specific extractables in drug product by interpreting standard extractables data (model streams, scale, timepoints)

    VALIDATION SERVICES

    What?
    Process Specific Extractables Report: Quantitative list of process specific extractables (or potential leachables)

    Where?
    Extractables Study Service

      Evaluate & Mitigate

      Leachables Report
      Why?
      Calculate risk associated to drug intake on the basis of extractables compounds
      If evaluation fails, mitigate risk with a leachables study or change process design

      VALIDATION SERVICES

      What?
      Patient Safety Report
      Leachables Report

      Where?
      Patient Safety
      Evaluation Service Leachables Study Service

        Maximize

        Patient Safety

        Maximize efforts toward assuring patient safety
          • Extractables evaluation. By considering a worst-case  and a model solvent approach, extractables data will be compiled through our analytical studies or via our Emprove® Program.
          • Patient safety assessment. A patient safety evaluation is performed by an in-house toxicologist to determine the potential risk to patients. Extractables and/or leachables data, the manufacturing process, and drug posology are used to calculate the potential daily intake of potential leachables compared to exposure limits.
          • Leachables testing. When required by a risk-based approach, a leachables study is conducted using end-user process conditions and products to identify compounds from the filtration device and single-use systems, followed by a patient safety assessment.

          The resulting extractables or leachables data package either proves and affirms the E&L safety of your manufacturing process or establishes the need for additional evaluation. Validation Services can further help you mitigate risks with flushing studies and alternative process designs.

          Request a quote and get started today. 

          Related Product Resources

          Validation Services Extractables and Leachables Testing Brochure
          Article: The Landscape for Single-use Systems
          Webinar: BioPhorum Raw Materials Risk Assessments
          Webinar: Advances in E&L Testing for Single-use Process Technology
          White paper:The Role of BPOG Extractables Data in the Effective Adoption of Single-use Systems

          Related Product Categories
          Final Sterile Filtration & Filling
          Enhance final filtration and sterile fill processes with pre-sterilized, single-use systems for optimized operations.
          Single-Use Assemblies
          Streamline biopharma manufacturing with Mobius® 2D and 3D single-use assemblies. From transport to final fill, achieve flexible fluid management.
          Related Applications
          Monoclonal Antibody Manufacturing
          Monoclonal antibody manufacturing is a highly templated approach used to produce mAb-based immunotherapies. Robust, scalable process solutions are required at every step to ensure high therapeutic concentration and process safety, while meeting speed-to-market and cost containment concerns.
          Classical Pharmaceutical Formulation & Manufacturing
          Manufacturing the final dosage form of a small molecule drug requires robust quality and design in development of the formulation and production of the final product. Explore solutions and best practices to advance and accelerate small molecule pharmaceuticals, from development to commercialization.
          Gene Therapy Manufacturing
          Growing use of gene therapies is driving rapid innovation in an evolving global market. Manufacturers bringing new gene therapies to life face complex challenges, requiring an experienced partner capable of integrating vector manufacturing, testing, safety, process development, and regulatory compliance.
          Vaccine Manufacturing
          From early phase development, through downstream purification to large scale vaccine production: learn more about vaccine process development and application expertise.
          Related Services
          Emprove® Filters and Single-Use Components
          Answering industry-wide demand for increased transparency, our Emprove® Filter and Single-use Components portfolio helps biopharmaceutical manufacturers advance their product development with confidence.
          Single-Use and Filter Validation Services
          Accelerate and simplify your path to market by using our Validation Services to select, test, and validate your filters, assemblies, and single-use systems for drug manufacturing and processing.
          Bacterial Retention Testing
          Required by regulatory bodies worldwide, bacterial retention testing (BRT) is a critical step in filter validation. Our skilled validation specialists conduct BRT using each end-user’s worst-case biopharmaceutical processing conditions to ensure a best-case outcome.
          Chemical Compatibility Testing
          Our physical and chemical compatibility testing services help you comply with GMP guidelines worldwide, proving that your biopharmaceutical filters and single-use systems are not reactive, additive, or absorptive upon contact with drug product.
          Filter Integrity Testing
          Our integrity testing for sterilizing-grade filters can help you set a test specification for your drug product, then check for leaks or filter damage using pre-use and post-use testing as recommended or required by regulatory agencies and the Parenteral Drug Association (PDA).
          Validation Service Levels
          Discover an easier way to global compliance with our validation services, simplifying your process from the start with two predefined service levels and globally harmonized testing.
          Validation Services Consultancy
          For local assistance and rapid response to your filtration validation needs, BioReliance® Validation Services offers a global network of highest-quality laboratories with in-country and in-region experts at strategic geographic centers.
          Sign In To Continue

          To continue reading please sign in or create an account.

          Don't Have An Account?